New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Ericsson

ERIC

Technology Communication Equipment

Ericsson’s revenue for fiscal 2025 (year ended December 2025) was $24.2 billion, up 3.15% from fiscal 2024.

Revenue
+4.35%
EPS
−48.6%
Free cash flow
−30.0%
Total debt
+0.61%

Quarter to September 2026, against a year earlier

9.77 0.40 −3.93%

After hours trading: 9.71, down 0.61%, last trade Fri 6:54pm Eastern.

Market cap
$30.5B
P/E
16.0×
Fwd P/E FY26e
—
Dividend yield
3.27%
F-score
8/9
ROIC
19.1%
Net debt / EBITDA
−0.5×
Payout ratio
0.5×

Ericsson (ERIC) news

Stories the last two months, newest first

  1. Commentary ·

    Ericsson pursues opportunities in non-terrestrial networks

    Ericsson is extending its Mobile Core position alongside Huawei and Nokia while pursuing opportunities in emerging Non Terrestrial Networks. Higher network hardware costs and slower 5G rollouts may constrain operator spending. The expansion could support Ericsson’s Networks business, but profitability still depends on cost reductions and execution, while Enterprise and Vonage remain potential sources of margin risk.

    Reported by Simply Wall St

  2. Commentary ·

    Hotchkis & Wiley says Ericsson earnings remain below normal

    Hotchkis & Wiley’s Focused Global Value Fund returned 6.42% in Q3 2026, beating the MSCI World Value Index’s 3.84%. The fund said Ericsson’s earnings remain below normal as its Enterprise business loses money and market share gains in Japan have yet to generate material revenue. It considered the increase in input costs manageable.

    Reported by Insider Monkey

  3. Deal ·

    Ericsson advances connected healthcare research with Singtel and Singapore health system

    Ericsson announced 6G healthcare initiatives with Singtel and Singapore’s National University Health System, including a 6G AI centre. It also signed an MoU with the two organizations to advance connected healthcare using 5G-Advanced and early 6G research. Its shares were up 20.5% year to date and 12.7% over 30 days.

    Reported by 2: Simply Wall St. · Simply Wall St.

  4. Commentary ·

    Ericsson valuation analysis says shares are broadly in line with estimated value

    Ericsson shares have risen 123.6% over three years and recently closed at SEK 103.20. Its latest 12-month free cash flow was about SEK 28.5 billion, while DCF assumptions implied a value broadly in line with the current price. Simply Wall St narratives differed, with one seeing 20% upside and the consensus view highlighting execution risks.

    Reported by Simply Wall St.

  5. Deal ·

    Verizon plans nationwide rollout of Ericsson’s Intelligent Controller

    Verizon will roll out Ericsson’s Intelligent Controller across its US network, using AI applications to automate network management. Field tests reported up to 8.9% higher downlink and 8% higher uplink throughput, and automated LTE-to-5G handovers for fixed wireless devices. Verizon plans additional rApps to improve performance and operational efficiency as it pursues Level 4 network autonomy.

    Reported by 2: PR Newswire · verdict.co.uk

  6. Deal ·

    Ericsson, Singtel and NUHS establish connected healthcare research centre

    NUHS, Singtel and Ericsson signed an MOU to establish the National University XG AI Centre, a healthcare R&D testbed developing applications using 5G-Advanced and future 6G connectivity, AI and robotics. The partners will collaborate on research, clinical testing, training and funding, building on five years of work including an indoor 5G network at NUH.

    Reported by PR Newswire

  7. Product ·

    Ericsson launches 5G-based system to detect and track drones

    Ericsson introduced a 5G-based Integrated Sensing and Communication system that uses existing network infrastructure to detect and track unconnected, low-flying drones. The offering targets defense, public safety, and critical infrastructure customers. Small-scale pilots are planned for 2027, with broader deployments expected from 2028; customer adoption and conversion of trials into long-term contracts will determine its commercial impact.

    Reported by Simply Wall St.

More headlines